Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New online tool aims to ease life after head and neck cancer

NCT ID NCT04208490

Symptom relief Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial tests a web-based tool called HN-STAR that helps head and neck cancer survivors and their doctors manage ongoing health issues after treatment. About 357 survivors from 20 to 36 cancer clinics will either use the tool or get usual care. The goal is to see if the tool improves quality of life and ensures care follows expert guidelines.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
web-based survivorship tool (HN-STAR)
What this could lead to
If it works, this tool could help head and neck cancer survivors feel better and get care that matches guidelines.
What could go wrong
This is a relatively small trial testing a digital tool, not a drug. The tool may not improve outcomes more than usual care, and results may not apply to all survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

357 people

The number who actually took part.

Started

Feb 2021

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Survivor Inclusion Criteria: * Age ≥18 years. * Diagnosis of primary or locoregionally recurrent head and neck squamous cell carcinoma, specifically oral cavity, larynx, oropharynx, hypopharynx, and unknown squamous cell carcinoma primary. * Completed chemotherapy and/or radiation therapy with curative intent for head and neck squamous cell carcinoma ≤ 24 months prior to designated clinician visit. * Deemed free of disease at last assessment. * Cognitively and physically able to complete study survey per local NCORP site staff discretion. * Scheduled for a clinic visit with a provider who has agreed to participate in this study and meets requirements for the arm to which their practice has been assigned (the practice designated clinician) for routine follow-up. * Willing to complete study assessments 3, 6, and 9 months after the designated clinic visit either 1) remotely (via telephone or videoconference using smartphone, tablet, or computer) or 2) at the clinic to complete study assessments on a clinic tablet or computer. Survivor Exclusion Criteria: * In active cancer treatment (including hormone therapy) for any other cancer, excluding local therapy for non-melanoma skin cancer. * Evidence of prior cancer (excluding non-melanoma skin cancer) within 3 years of the designated clinician visit. * Head and neck tumor histology of lymphoma, adenocarcinoma or melanoma. * Recurrent, persistent, or progressive disease at last assessment (per scan or clinical assessment). * Does not speak or read English, because the HN-STAR tool is only available in English at this time. * Received only surgery as treatment for head and neck cancer. * Current, planned enrollment, or in follow-up on another interventional symptom management study protocol, as per patient self-report or research staff members' knowledge at the time of consent. Concurrent participation in treatment or imaging studies is allowed. Designated Clinician Inclusion Criteria: * Age \> = 18 years * MD, DO, NP, or PA * Able to speak and read English, because the HN-STAR tool is only available in English at this time. * Routinely provides care for cancer patients or survivors. * Willing to complete study-specific trainings and incorporate HN-STAR or provide usual care in a routine follow-up care visit Stakeholders Inclusion Criteria: * Age \> = 18 * Member of the practice clinical or administrative team who is involved in the oversight of the delivery of head and neck cancer survivorship care or who would make decisions about implementing head and neck survivorship tools such as HN-STAR. This could include clinic administrators, nurse navigators, key clinical team members, program directors, and other staff (e.g., service line or nursing leaders). * Employed for at least one month at the practice. * Able to speak and reads English, because the HN-STAR tool is only available in English at this time. Stakeholder Exclusion Criteria: * Is the designated clinician at the practice. Primary Care Provider Inclusion Criteria: * Provides primary care (general preventative care) to a survivor enrolled in the HN-STAR study. * Age \>= 18 * MD, DO, NP, or PA Primary Care Provider Exclusion Criteria: * Provides Oncology Care

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Head and neck cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

head and neck cancer Head and Neck Neoplasms head and neck squamous cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Head and neck cancer

Contacts and locations

Locations

  • AnMed Health Cancer Center

    Anderson, South Carolina, 29621, United States

  • Ascension Columbia Saint Mary's Hospital - Milwaukee

    Milwaukee, Wisconsin, 53211, United States

  • Ascension Saint Elizabeth Hospital

    Appleton, Wisconsin, 54915, United States

  • Ascension Saint Francis - Reiman Cancer Center

    Franklin, Wisconsin, 53132, United States

  • Aspirus Cancer Care - James Beck Cancer Center

    Rhinelander, Wisconsin, 54501, United States

  • Aspirus Cancer Care - Stevens Point

    Stevens Point, Wisconsin, 54481, United States

  • Aspirus Langlade Hospital

    Antigo, Wisconsin, 54409, United States

  • Aspirus Regional Cancer Center

    Wausau, Wisconsin, 54401, United States

  • Augusta University Medical Center

    Augusta, Georgia, 30912, United States

  • Beebe Health Campus

    Rehoboth Beach, Delaware, 19971, United States

  • Beebe South Coastal Health Campus

    Frankford, Delaware, 19945, United States

  • Bon Secours Saint Francis Medical Center

    Midlothian, Virginia, 23114, United States

  • Carle Cancer Center

    Urbana, Illinois, 61801, United States

  • Carle Physician Group-Mattoon/Charleston

    Mattoon, Illinois, 61938, United States

  • Carle at The Riverfront

    Danville, Illinois, 61832, United States

  • Carle on Vermilion

    Danville, Illinois, 61832, United States

  • Decatur Memorial Hospital

    Decatur, Illinois, 62526, United States

  • Geisinger Medical Center

    Danville, Pennsylvania, 17822, United States

  • Harold Alfond Center for Cancer Care

    Augusta, Maine, 04330, United States

  • Iowa Methodist Medical Center

    Des Moines, Iowa, 50309, United States

  • John H Stroger Jr Hospital Cook County

    Chicago, Illinois, 60612, United States

  • Kingman Regional Medical Center

    Kingman, Arizona, 86401, United States

  • Licking Memorial Hospital

    Newark, Ohio, 43055, United States

  • Maine Medical Partners - South Portland

    South Portland, Maine, 04106, United States

  • Maine Medical Partners Otolaryngology

    Portland, Maine, 04101, United States

  • MedStar Georgetown University Hospital

    Washington D.C., District of Columbia, 20007, United States

  • MedStar Washington Hospital Center

    Washington D.C., District of Columbia, 20010, United States

  • Medical University of South Carolina

    Charleston, South Carolina, 29425, United States

  • Mercy Medical Center - Des Moines

    Des Moines, Iowa, 50314, United States

  • Montefiore Medical Center - Moses Campus

    The Bronx, New York, 10467, United States

  • Montefiore Medical Center-Einstein Campus

    The Bronx, New York, 10461, United States

  • OptumCare Cancer Care at Charleston

    Las Vegas, Nevada, 89102, United States

  • OptumCare Cancer Care at Fort Apache

    Las Vegas, Nevada, 89148, United States

  • OptumCare Cancer Care at Seven Hills

    Henderson, Nevada, 89052, United States

  • Park Nicollet Clinic - Saint Louis Park

    Saint Louis Park, Minnesota, 55416, United States

  • Phoebe Putney Memorial Hospital

    Albany, Georgia, 31701, United States

  • Prisma Health Cancer Institute - Butternut

    Greenville, South Carolina, 29605, United States

  • Prisma Health Cancer Institute - Faris

    Greenville, South Carolina, 29605, United States

  • Queen's Medical Center

    Honolulu, Hawaii, 96813, United States

  • Regions Hospital

    Saint Paul, Minnesota, 55101, United States

  • Reid Health

    Richmond, Indiana, 47374, United States

  • Rocky Mountain Cancer Centers-Boulder

    Boulder, Colorado, 80304, United States

  • Saint Francis Cancer Center

    Greenville, South Carolina, 29607, United States

  • Saint Francis Hospital

    Greenville, South Carolina, 29601, United States

  • Saint Vincent Hospital Cancer Center Green Bay

    Green Bay, Wisconsin, 54301, United States

  • Sanford Roger Maris Cancer Center

    Fargo, North Dakota, 58122, United States

  • Sanford USD Medical Center - Sioux Falls

    Sioux Falls, South Dakota, 57117-5134, United States

  • Spartanburg Medical Center

    Spartanburg, South Carolina, 29303, United States

  • ThedaCare Regional Cancer Center

    Appleton, Wisconsin, 54911, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.